반응 #157984

ord-33004f25daeb4eaa95b6c15a34f6c655

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타The aqueous phase is removed
  2. 2
    추출extracted with ethyl acetate
  3. 3
    건조The combined organic phases are dried over sodium sulfate
  4. 4
    여과The solids are filtered off
  5. 5
    workup.DISTILLATIONthe solvent is distilled off
  6. 6
    기타The residue is purified by chromatography

실험 절차

To a solution of 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid (E, 160 mg) in dichloromethane (5 ml) are added, at room temperature, 2-chlorocyclohexanol (57 mg), 4-dimethylaminopyridine (4 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (94 mg). The mixture is stirred overnight, and water is then added. The aqueous phase is removed and extracted with ethyl acetate. The combined organic phases are dried over sodium sulfate. The solids are filtered off and the solvent is distilled off. The residue is purified by chromatography. This gives 2-chlorocyclohexyl 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylate (100 mg, 50%).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08822693B2uspto-grants-2014_09